Life Science Logistics expands its Indianapolis facility
More CII and refrigerated storage
Life Science Logistics (Dallas) has opened a 2,350-sq.ft vault (pictured) for CII (Class II controlled substances) and also a 2,700-sq.ft. space for refrigerated (2-8°C) storage at its existing Indianapolis facility. That location now have just under 400,000 sq.ft of capacity.
“We’re seeing increased demand for refrigerated space from our pharmaceutical and biotech clients,” said Richard Beeny, CEO, adding that LSL chose to expand at its Indianapolis location because of Indiana’s geographic reach and the city’s tax advantages for its clients. The CII expansion was driven, in part, by the reclassification, last year, of CIII hydrocodone to CII.
Life Science Logistics has four US locations (Dallas, Indianapolis, Baltimore and Atlanta, totaling 1.35 million sq. ft of capacity exclusively for life sciences products. In addition to the storage, it offers 3PL logistics services, including distribution, order to case and regulatory compliance.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
